Preclinical Studies

PRECLINICAL STUDIES WHITE PAPER & ARTICLES

  • Avoiding Headaches In Today’s Complex Phase I Landscape
    Avoiding Headaches In Today’s Complex Phase I Landscape

    Statistics suggest that Phase I clinical trials, while by no means free of challenges, are more manageable than later phases. They tend to take less time and cost less money; the drugs they test have a comfortable 70% chance of moving on to the next phase.(1) These figures are a reprieve from some of the realities that make Phase I trials, in some respects, uniquely stressful. The absence of a safety profile for the drug being tested can make subject recruitment particularly challenging. And any errors or delays in Phase I can set the tone for the rest of the drug development process.

  • Educating Tomorrow’s Clinical Researchers
    Educating Tomorrow’s Clinical Researchers

    A drug’s journey from proof of concept to FDA approval is a years-long, far-reaching process in which healthcare, business and government each play important roles. For aspiring clinical researchers hoping to navigate this sprawling field, there’s certainly a lot to learn. We thought we’d take a look at a pair of initiatives educating students in healthcare and pharmacology in the many aspects of clinical research. Driving these initiatives is the understanding that clinical research shouldn’t be a niche skill, that strengthening knowledge of clinical research among all kinds of healthcare providers will strengthen the healthcare industry as a whole.

  • The Importance Of Stakeholder Research In Rare Disease Drug Development
    The Importance Of Stakeholder Research In Rare Disease Drug Development

    Leading manufacturers increasingly employ stakeholder research early in development to better identify the needs of patients and providers.

  • Integrated Workflows: The Unsexy Plumbing Of Clinical Trials
    Integrated Workflows: The Unsexy Plumbing Of Clinical Trials

    There is no doubt that clinical research is critical to the advancement of medicine and public health. But conducting such research is a complex, resource intensive endeavor that relies on a multitude of stakeholders, workflows, processes, and information systems.

  • Advancing Safety and Efficacy Studies with Novel Surgical Applications
    Advancing Safety and Efficacy Studies with Novel Surgical Applications

    Novel therapeutics such as gene and cell therapies, nanoparticles, and combination products requiring targeted delivery,  novel treatments for wound healing, cardiovascular disease, and bone regeneration,  and new medical device technologies call for innovative surgical procedures in preclinical trials to determine safety and efficacy.

More From preclinical white papers and articles

PRECLINICAL APPLICATIONS & STUDIES

More From Preclinical applications and studies

PRECLINICAL SUPPLIERS

  • PRA Health Sciences
    PRA Health Sciences

    PRA is a global Clinical Research Organization providing services through all phases of clinical development. PRA has supported over 3,100 clinical trials in more than 80 countries on 6 continents through our global offices. PRA's therapeutic expertise, global reach, and project experience with local knowledge enable our project teams to deliver consistent and on time performance for our clients.

  • MPI Research
    MPI Research

    MPI Research, with global headquarters in Mattawan, Michigan, provides discovery, safety evaluation, bioanalytical, and analytical services to the biopharmaceutical, medical device, animal health, and chemical industries.

More From Preclinical Suppliers